EndoClot Plus, Inc. (EPI) is a privately founded company in Santa Clara, California.  In collaboration with endoscopists and biomaterial scientists, EPI developed a breakthrough technology to control bleeding in the gastrointestinal tract (GIT) by spraying a unique and proprietary powder directly to the wound during endoscopy.the hemostatic powder directly to the wound during endoscopy. The EndoClot^® Polysaccharide Hemostatic System (EndoClot^® PHS)is being sold in Europe and other selected internatinal markets

EndoClot^® PHS consists of Absorbable Modified Polymers (AMP^®) and a unique powder delivery system (applicator). EPI provides new therapeutic solutions to the world market for gastrointestinal (GI) endoscopy